Trade Mark Journal No.2025/038 19 September 2025
UK00004260068 5 September 2025 (42)
VELOCIVAX
International priority date claimed: 12 March 2025
(United States of America)
(99080151)
- Class 42
- Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid molecule delivery development and production; genetic engineering services utilizing a collection of genetic technologies for the production and delivery of immune modulators; scientific, laboratory and medical research in the field of genetic engineering technologies; scientific laboratories performing nucleic acid molecule development and nucleic acid molecule delivery development; scientific research and development, namely, development of nucleic acid molecule and nucleic acid molecule delivery for others.
Regeneron Pharmaceuticals, Inc.
Representative: Appleyard Lees IP LLP